SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal pest populations, has launched its Evolve(TM) Soft Bait product at Ace Hardware franchise locations in California; the franchise also began selling SenesTech’s Isolate(TM) bait system. According to the announcement, this is the first time a traditional retail store has carried SenesTech rodent fertility control solutions. Evolve is the first and only soft bait product featuring breakthrough, next-generation technology designed to decrease rodent populations through nonlethal methods. “California-based Scarborough Ace Hardware, as well as Scarborough Home and Garden, are the first retail outlets to commit to SenesTech’s line,” said SenesTech president and CEO Joel Fruendt in the press release. “They will also be among the first in the U.S. to receive shipments of Evolve based on their recent preorder. We expect the penetration of retail and big box to rapidly accelerate, especially with the launch of Evolve and its retail-friendly soft bait profile and packaging. Evolve was developed to offer customers a soft bait product that has similar efficacy to ContraPest but in a format that is easier to deploy, and is ideally suited for use by do it yourself consumers. We are pleased to be partnering with the team at Scarborough Ace Hardware to provide their customers with an innovative solution to address their rodent issues.”
In addition, SenesTech also announced the pricing of its public offering. According to the announcement, the offering is comprised of 3,846,154 shares of its common stock (or prefunded warrants in lieu thereof) and accompanying Series D warrants to purchase up to 3,846,154 shares of its common stock (Series D warrants) and Series E warrants to purchase up to 3,846,154 shares of its common stock (Series E warrants, together with Series D warrants, collectively the series warrants). The offering is at a combined price of $1.30 per share of common stock (or prefunded warrant in lieu thereof) and associated series warrants. The announcement noted that the series warrants, which will be immediately exercisable upon issuance, have an exercise price of $1.30 per share. Series D warrants will expire five years following the initial exercise date with Series E warrants set to expire 18 months following the initial exercise date. The public offering should close on or about Nov. 30, 2023, and is subject to customary closing conditions. Gross proceeds from the offering are anticipated to total an estimated $5 million before standard agent’s fees and other offering expenses are deducted. SenesTech plans to use the proceeds from the offering for general corporate purposes, including R&D, capital expenditures, working capital and general and administrative expenses, as well as potential acquisitions or investments.
To view the full press release, visit https://nnw.fm/wlOAT and https://nnw.fm/iGDbx
About SenesTech Inc.
SenesTech is committed to improving the health of the world by humanely managing animal pest populations through fertility control. The company is expert in fertility control to manage animal pest populations. SenesTech invented ContraPest, the only U.S. EPA-registered contraceptive for male and female rats, and Evolve, an EPA-designated minimum risk contraceptive currently offered for rats. ContraPest and Evolve fit seamlessly into all integrated pest-management programs, significantly improving the overall goal of effective pest management. The company strives for clean cities, efficient businesses and happy households by providing a product designed to be humane, effective and sustainable. For more information about the company, please visit www.SenesTech.com.
NOTE TO INVESTORS: The latest news and updates relating to SNES are available in the company’s newsroom at https://nnw.fm/SNES
About NetworkNewsWire
NetworkNewsWire (“NNW”) is a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled recognition and brand awareness. NNW is where breaking news, insightful content and actionable information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: https://www.NetworkNewsWire.com/Disclaimer
NetworkNewsWire
New York, NY
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is powered by IBN
